Trial Profile
A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Levocetirizine Dihydrochloride 5 mg Tablets With Xyzal 5 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fed Condition
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2012
Price :
$35
*
At a glance
- Drugs Levocetirizine (Primary)
- Indications Allergic rhinitis; Dermatitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis; Urticaria
- Focus Pharmacokinetics
- 10 Apr 2012 New trial record